Neuronetics Announces Proposed Public Offering of Common Stock
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a…
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a…
HOUSTON, Jan. 28, 2021 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing…
First to Demonstrate Clinical Efficacy Against COVID-19 and Both UK and South Africa Variants Strong…
Lille, France; Cambridge, MA; January 28, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical…
CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical…
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
New space is ideally equipped and located in the heart of Buffalo’s urban renewal WILLIAMSVILLE,…
Idorsia will publish its full year financial results 2020 on Thursday February 4, 2021, at…
OSE is advancing an “Immunotherapy 2.0” future by leveraging MAbSilico’s artificial intelligence-powered software solutions and…
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Biosenta Inc. (“Biosenta” or the “Company”) listed on…
DAVIS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), an…
REHOVOT, Israel and WILMINGTON, Del., Jan. 28, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (NASDAQ:…
Clinical team led by neurological gene therapy expert, Dr. Krystof Bankiewicz, joins AskBio RESEARCH TRIANGLE…
– Company licenses exclusive worldwide rights to develop, manufacture and commercialize targeted, highly specific immunosuppressive…
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) in…
Upon closing, the company to meet Nasdaq listing requirements without the need to effect a…
Webinar on Thursday, February 4, at 12:00 PM ET REDWOOD CITY, Calif., Jan. 28, 2021…
George Goldsmith, Chairman & CEO, to deliver opening day keynote on 3 February London, UK,…